APA (7th ed.) Citation

Hongfu Cai, Lisheng Huang, & Zhiwei Zheng. (2024). Toripalimab plus chemotherapy in the treatment of metastatic triple-negative breast cancer: A cost-effectiveness analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Hongfu Cai, Lisheng Huang, and Zhiwei Zheng. Toripalimab Plus Chemotherapy in the Treatment of Metastatic Triple-negative Breast Cancer: A Cost-effectiveness Analysis. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Hongfu Cai, et al. Toripalimab Plus Chemotherapy in the Treatment of Metastatic Triple-negative Breast Cancer: A Cost-effectiveness Analysis. Frontiers Media S.A., 2024.